Virtus Investment Advisers, LLC
HARTFORD CT · SEC CIK 0000019481
$4.29亿2026Q2 申报市值
463持仓数
7.6%前十大占比 · 第一大 0.9%
60 / 55新建仓 / 清仓
26Q126Q2
前十大持仓 占组合比例
2026Q2 买入最多 按季末市值估算
MRVL 新建仓+$339.42万
DVN 新建仓+$309.33万
WDC 新建仓+$287.36万
GLW 新建仓+$274.03万
UAL 新建仓+$266.70万
2026Q2 卖出最多 按季末市值估算
DAY ONE BIOPHARM 清仓-$216.52万
LIN 清仓-$207.62万
HSY 清仓-$205.87万
LYV 清仓-$197.16万
KO 清仓-$196.22万
2026Q2 持仓明细 点表头排序 · 每页 100 行
导出 CSV 🔒| 代码 | 名称 | 市值 ▼ | 占比 | 股数 | 变动股数 | 变动 | 估算买卖额 | 操作 |
|---|---|---|---|---|---|---|---|---|
| CTSH | COGNIZANT TECHNOLOGY SOLUTIO | $0 | 0.00% | 0 | -22,418 | -100.0% | -$137.53万 | 清仓 |
| DASH | DOORDASH INC | $0 | 0.00% | 0 | -9,152 | -100.0% | -$137.42万 | 清仓 |
| — | APELLIS PHARMACEUTICALS INC | $0 | 0.00% | 0 | -33,462 | -100.0% | -$134.62万 | 清仓 |
| AXON | AXON ENTERPRISE INC | $0 | 0.00% | 0 | -3,109 | -100.0% | -$132.04万 | 清仓 |
| — | KALVISTA PHARMACEUTICALS INC | $0 | 0.00% | 0 | -49,927 | -100.0% | -$100.50万 | 清仓 |
| ASND | ASCENDIS PHARMA A/S | $0 | 0.00% | 0 | -3,830 | -100.0% | -$87.60万 | 清仓 |
| — | ESPERION THERAPEUTICS INC NE | $0 | 0.00% | 0 | -219,293 | -100.0% | -$60.09万 | 清仓 |
| — | ARCELLX INC | $0 | 0.00% | 0 | -3,794 | -100.0% | -$43.56万 | 清仓 |
| LENZ | LENZ THERAPEUTICS INC | $0 | 0.00% | 0 | -46,542 | -100.0% | -$42.59万 | 清仓 |
| — | CENTESSA PHARMACEUTICALS PLC | $0 | 0.00% | 0 | -10,286 | -100.0% | -$40.86万 | 清仓 |
| — | TERNS PHARMACEUTICALS INC | $0 | 0.00% | 0 | -6,058 | -100.0% | -$31.94万 | 清仓 |
| — | MONROE CAP CORP | $0 | 0.00% | 0 | -62,628 | -100.0% | -$28.81万 | 清仓 |
| — | NUVALENT INC | $0 | 0.00% | 0 | -2,602 | -100.0% | -$26.66万 | 清仓 |
| — | SOLENO THERAPEUTICS INC | $0 | 0.00% | 0 | -5,243 | -100.0% | -$17.55万 | 清仓 |
| FULC | FULCRUM THERAPEUTICS INC | $0 | 0.00% | 0 | -20,974 | -100.0% | -$16.09万 | 清仓 |
| KROS | KEROS THERAPEUTICS INC | $0 | 0.00% | 0 | -12,676 | -100.0% | -$13.99万 | 清仓 |
| — | MEREO BIOPHARMA GROUP PLC | $0 | 0.00% | 0 | -125,662 | -100.0% | -$4.15万 | 清仓 |
| — | GOSSAMER BIO INC | $0 | 0.00% | 0 | -75,746 | -100.0% | -$2.49万 | 清仓 |